Ojeda-Fernández Luisa, Baviera Marta, Foresta Andreana, Tettamanti Mauro, Zambon Antonella, Macaluso Giulia, Schena Simone, Leoni Olivia, Fortino Ida, Roncaglioni Maria Carla, Parati Gianfranco
Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Laboratory of Geriatric Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Front Cardiovasc Med. 2023 Sep 12;10:1244002. doi: 10.3389/fcvm.2023.1244002. eCollection 2023.
BACKGROUND: COVID-19 has been associated with a higher risk of post-acute complications. Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 survivors of the first and second/third pandemic waves in Lombardy, in both hospitalized and non-hospitalized COVID-19 patients. METHODS AND RESULTS: We included adults aged ≥40 years infected during the first and second/third waves of COVID-19 pandemic. The follow-up initiated 30 days after COVID-19 diagnosis and continued up to 9 months. Hazard ratios (HRs) and 95% confidence intervals (CIs) of the post-acute cardiovascular outcomes were calculated against an inverse probability treatment weighted control group. Subgroup analysis were performed by age classes, sex, previous cardiovascular disease and stratified by COVID-19 hospitalization status to explore the impact of COVID-19 severity on outcomes. Compared to the control group, COVID-19 patients had an increased risk of hospitalization for any cardiovascular complications (HR 1st wave 1.53 95% CI: 1.38-1.69; HR 2nd/3rd wave 1.25 95% CI: 1.19-1.31) and for individual cardiovascular outcomes, although HRs were higher in COVID-19 group from the 1st pandemic wave. The results were confirmed in the subgroup analyses. Of note, the risk for any cardiovascular disease was also evident even among individuals who were not hospitalized during the acute phase of the infection. CONCLUSION: Our results provide evidence that COVID-19 is a risk factor for post-acute cardiovascular complications among different pandemic waves regardless of COVID-19 severity, age, sex and a history of cardiovascular diseases. Care strategies of people with COVID-19 should include cardiac monitoring.
Front Cardiovasc Med. 2023-9-12
Cochrane Database Syst Rev. 2022-2-1
JAMA Intern Med. 2023-6-1
Lancet Diabetes Endocrinol. 2023-2
Nutr Metab Cardiovasc Dis. 2023-7
Cell Death Differ. 2022-10
Front Cardiovasc Med. 2022-8-5
Lancet Infect Dis. 2022-8
Int J Cardiol Heart Vasc. 2022-3-28
Eur Heart J. 2022-3-14